Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F McCarty

Showing results (101-110 of 153) with videos related to

Pageof 16
Sort By:
Medical Hypotheses|June 22, 2000
High-dose pyridoxine as an 'anti-stress' strategyM F McCarty
Medical Hypotheses|June 22, 2000
Prenatal high-dose pyridoxine may prevent hypertension and syndrome X in-utero by protecting the fetus from excess glucocorticoid activityM F McCarty
The American Journal of Clinical Nutrition|October 28, 1999
The alcohol paradoxM F McCarty
Medical Hypotheses|September 14, 2000
Co-administration of equimolar doses of betaine may alleviate the hepatotoxic risk associated with niacin therapyM F McCarty
Medical Hypotheses|September 5, 2002
Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimenM F McCarty
Medical Hypotheses|June 27, 2001
Androgenic progestins amplify the breast cancer risk associated with hormone replacement therapy by boosting IGF-I activityM F McCarty
Medical Hypotheses|June 27, 2001
Hepatic monitoring of essential amino acid availability may regulate IGF-I activity, thermogenesis, and fatty acid oxidation/synthesisM F McCarty
Medical Hypotheses|January 3, 2001
Supplemental creatine may decrease serum homocysteine and abolish the homocysteine 'gender gap' by suppressing endogenous creatine synthesisM F McCarty
Medical Hypotheses|January 3, 2001
Suppression of dolichol synthesis with isoprenoids and statins may potentiate the cancer-retardant efficacy of IGF-I down-regulationM F McCarty
Medical Hypotheses|August 23, 2001
Versatile cytoprotective activity of lipoic acid may reflect its ability to activate signalling intermediates that trigger the heat-shock and phase II responsesM F McCarty
Pageof 16

Showing results (101-110 of 153) with videos related to

Sort By:
Pageof 16
Medical Hypotheses|June 22, 2000
High-dose pyridoxine as an 'anti-stress' strategyM F McCarty
Medical Hypotheses|June 22, 2000
Prenatal high-dose pyridoxine may prevent hypertension and syndrome X in-utero by protecting the fetus from excess glucocorticoid activityM F McCarty
The American Journal of Clinical Nutrition|October 28, 1999
The alcohol paradoxM F McCarty
Medical Hypotheses|September 14, 2000
Co-administration of equimolar doses of betaine may alleviate the hepatotoxic risk associated with niacin therapyM F McCarty
Medical Hypotheses|September 5, 2002
Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimenM F McCarty
Medical Hypotheses|June 27, 2001
Androgenic progestins amplify the breast cancer risk associated with hormone replacement therapy by boosting IGF-I activityM F McCarty
Medical Hypotheses|June 27, 2001
Hepatic monitoring of essential amino acid availability may regulate IGF-I activity, thermogenesis, and fatty acid oxidation/synthesisM F McCarty
Medical Hypotheses|January 3, 2001
Supplemental creatine may decrease serum homocysteine and abolish the homocysteine 'gender gap' by suppressing endogenous creatine synthesisM F McCarty
Medical Hypotheses|January 3, 2001
Suppression of dolichol synthesis with isoprenoids and statins may potentiate the cancer-retardant efficacy of IGF-I down-regulationM F McCarty
Medical Hypotheses|August 23, 2001
Versatile cytoprotective activity of lipoic acid may reflect its ability to activate signalling intermediates that trigger the heat-shock and phase II responsesM F McCarty
Pageof 16